Cost Effectiveness of Preventing HIV Complications

Freedberg, Kenneth Alan

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Exploratory/Developmental Grants (R21)
• Project #: 1R21AI042006-01
• Application #: 2650073
• Study Section: Special Emphasis Panel (ZAI1-DET-A (M3))
• Project Start: 1997-09-30
• Project End: 1998-09-29
• Budget Start: 1997-09-30
• Budget End: 1998-09-29
• Support Year: 1
• Fiscal Year: 1997

Institution

• Name: Boston Medical Center
• DUNS #: 005492160
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02118

Publications

Noubary, Farzad; Hughes, Michael D (2012) Factors affecting timing of antiretroviral treatment initiation based on monitoring CD4 counts. J Acquir Immune Defic Syndr 61:326-33

Haas, David W; Kuritzkes, Daniel R; Ritchie, Marylyn D et al. (2011) Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clin Trials 12:277-85

Sax, Paul E (2010) Assessing risk for cardiovascular disease in patients with human immunodeficiency virus: Why it matters. Circulation 121:620-2

Freedberg, K A; Paltiel, A D (1998) Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion. Pharmacoeconomics 14:165-74